Georges J C, Mahassen P, Mattei M F, Dopff C, de Faup-Rocheton B
Laboratoire de microbiologie, CHU Nancy-Brabois.
Agressologie. 1992;33 Spec No 3:151-3.
The HSV (1 or 2) is the cause of serious pulmonary infections among patients who have had a transplantation. This study in retrospect is based on the analysis of 145 patients who underwent a cardiothoracic transplant at the CHU. in Nancy. Confronted with clinical signs calling to mind breathing difficulties, the analysis of the broncho alveolar lavage (or of the bronchial brushing) revealed the viral aetiological agent. The answer from the laboratory is quickly available by immunofluorescence or by immunoperoxidase with viral anti-protein monoclonal antibodies and by the multiplication in vitro of the virus into cell cultures. The HSV 1 was responsible for 8 herpetic lung infections. The specific Acyclovir treatment was used 6 times successfully. When such a direction of treatment was impossible (in 2 cases) the outcome was fatal. The carry HSV is highly frequent and recurrences under immuno-suppressor treatment require an Acyclovir prophylaxis among patients admittedly carrying the virus in a pre-transplanted serum assessment.
单纯疱疹病毒(1型或2型)是移植患者严重肺部感染的病因。这项回顾性研究基于对145例在南锡大学中心医院接受心胸移植手术患者的分析。面对提示呼吸困难的临床症状,对支气管肺泡灌洗(或支气管刷检)的分析揭示了病毒病原体。通过免疫荧光、使用病毒抗蛋白单克隆抗体的免疫过氧化物酶法以及在细胞培养中使病毒体外增殖,可快速获得实验室检测结果。1型单纯疱疹病毒导致了8例疱疹性肺部感染。阿昔洛韦特异性治疗6次取得成功。当无法采用这种治疗方法时(2例),结果是致命的。携带单纯疱疹病毒的情况非常常见,在免疫抑制治疗期间复发时,对于在移植前血清评估中被确认携带该病毒的患者,需要进行阿昔洛韦预防。